Dr. Helen Cristina Stankiewicz Karita, MD

Dr. Stankiewicz Karita practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Stankiewicz Karita's NPI, 1568738417, was assigned on March 26, 2012. Dr. Stankiewicz Karita holds Washington license MD60539672.

Dr. Stankiewicz Karita's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Stankiewicz Karita's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Stankiewicz Karita is also affiliated with Zuckerberg San Francisco General Hospital and Trauma Center. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Stankiewicz Karita to 1 more hospital, 3 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stankiewicz Karita practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Stankiewicz Karita's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Stankiewicz Karita is licensed in Washington.

CMS data shows 239 Medicare services from Dr. Stankiewicz Karita across 7 procedure codes in 2024, for 142 Medicare patients. Medicare paid $22,844 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 142 Medicare patients who saw Dr. Stankiewicz Karita in 2024. The largest group is 65 to 74, with 64 patients. 74% of them have high cholesterol, and 70% have high blood pressure. 51% are also on Medicaid. Their average risk score is 3.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Stankiewicz Karita's median patient age at 61, with 36% women.

In 2024, Dr. Stankiewicz Karita wrote 23 Medicare Part D claims for 14 patients. 100% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $21 in total drug cost. In 2023, CMS named 22 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Stankiewicz Karita for performance year 2024, reported as part of a group. Dr. Stankiewicz Karita accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Stankiewicz Karita as offering telehealth.

Dmand AI links 19 papers to Dr. Stankiewicz Karita, published from 2017 to 2025. 2020 was the busiest year, with 4. The most frequent topics are COVID-19, Papillomavirus Infections and Anus Neoplasms. Dr. Stankiewicz Karita has published most often in Open Forum Infect Dis. Dr. Stankiewicz Karita's most frequent co-authors are Anna Wald, MD, MPH, Ruanne Vanessa Barnabas, MBCHB and Helen Y. Chu, MD, MPH.